Over 28 million Surgeries Canceled Around the World Because of COVID-19
Orthopedic surgeries are the ones most likely to be canceled.
As more states in the U.S. begin to allow elective surgery, a modeling study published in the British Journal of Surgery estimates that 28.4 million elective surgeries will be canceled or postponed this year because of COVID-19.
The model, which is based on information collected from 359 hospitals and 71 countries and then extended to cover 190 countries, estimates that each additional week of COVID-19-related “disruption” to hospital services results in 2.4 million cancellations.
Constructed by researchers at the University of Birmingham in Great Britain, the model projects that orthopedic procedures will top the list of the type of surgeries that will be canceled.
Meanwhile, in the U.S., individual states started to allow elective surgeries to be performed starting in late April. In many states, health officials have attached conditions to the permission to resume elective surgeries, such as having an ample supply of PPE on hand.
Yesterday Gov. Andrew Cuomo of New York announced that elective surgeries could begin in 12 more counties, bringing the total to 47 of the state’s 62 counties.
Conversations with Perry and Friends: Saar Mahna, J.D., MBA
July 7th 2025Perry Cohen, Pharm.D., a longtime member of the Managed Healthcare Executive editorial advisory board, is host of the "Conversations with Perry and Friends" podcast. In this episode, Cohen speaks with Saar Mahna, J.D., MBA, CEO and founder of Banjo Health, an artificial intelligence company focused on prior authorization.
Listen
Dupixent Is Linked to a Higher Risk of Psoriasis in Patients With Atopic Dermatitis
July 8th 2025AD and psoriasis were once thought to be opposites in terms of immune response, with AD linked to a Th2-dominant pathway and psoriasis driven by Th17 inflammation. However, newer research has shown that these diseases can overlap in patients and may even share common pathways.
Read More
Conversations With Perry and Friends: Paul Fronstin, Ph.D.
May 9th 2025Perry Cohen, Pharm.D., a longtime member of the Managed Healthcare Executive editorial advisory board, is host of the Conversations with Perry and Friends podcast. In this episode, his guest is Paul Fronstin, Ph.D., director of health benefits research at the Employee Benefit Research Institute.
Listen
Autoimmune Diseases Almost Double Mental Health Disorder Risk
July 7th 2025The prevalence of autoimmune disease patients with a mental health disorder is almost twice the number of patients without, suggesting there is a link between inflammation and conditions such as depression, anxiety disorder and bipolar disorder.
Read More
